About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 2

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Proof-of-concept Trial to Evaluate the Safety and Efficacy of Maraviroc in Severe Acute Respiratory Syndrome (SARS) Coronavirus-2 (CoV-2) Infected Patients Hospitalized for COVID-19

NCT04710199•Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Virus Diseases

Interventions

Maraviroc experimental group

Standard treatment

Locations

2

Spain

Locations (2)

Hospital Universitario Virgen del Rocio

Seville, Spain

Hospital Universitario Virgen del Rocío

Seville, Spain

Key Dates

Start Date

February 23, 2021

Primary Completion Date

July 8, 2021

Completion Date

July 8, 2021

Last Updated

May 6, 2023

Related Studies

Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease

NCT06113757

COVID-19 PneumoniaVirus Diseases+1 more

Tobacco Use and the Risk of COVID-19 and Adverse Outcomes

NCT05321433

COVID-19Respiratory Tract Infections+5 more

A Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children

NCT06205966

Virus Diseases in Children

Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)

NCT05606198

COMPLETEDPhase 2

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

NCT05422326

Influenza, HumanInfluenza in Birds+6 more

Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory

NCT05376124

Hepatitis B, ChronicVirus Diseases

View all related studies

Sponsors

Lead Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 6, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions